Published in Br J Psychiatry on September 01, 1978
Diazepam withdrawal syndrome: its prolonged and changing nature. Can Med Assoc J (1982) 2.09
Urinary and brain beta-carboline-3-carboxylates as potent inhibitors of brain benzodiazepine receptors. Proc Natl Acad Sci U S A (1980) 1.25
Genetic animal models of anxiety. Neurogenetics (2003) 1.00
Biochemical dissection of the gamma-aminobutyrate synapse. Biochem J (1983) 0.99
Behavioral and brain temperature responses to salient environmental stimuli and intravenous cocaine in rats: effects of diazepam. Psychopharmacology (Berl) (2007) 0.85
The effect of repeated doses of temazepam and nitrazepam on human psychomotor performance. Br J Clin Pharmacol (1985) 0.75
International Union of Pharmacology. XV. Subtypes of gamma-aminobutyric acidA receptors: classification on the basis of subunit structure and receptor function. Pharmacol Rev (1998) 4.37
Benzodiazepine receptors in rat brain. Nature (1977) 3.29
Specific benzodiazepine receptors in rat brain characterized by high-affinity (3H)diazepam binding. Proc Natl Acad Sci U S A (1977) 3.13
High densities of benzodiazepine receptors in human cortical areas. Nature (1977) 1.97
Interaction of convulsive ligands with benzodiazepine receptors. Science (1982) 1.72
[35S]t-butylbicyclophosphorothionate binds with high affinity to brain-specific sites coupled to gamma-aminobutyric acid-A and ion recognition sites. Mol Pharmacol (1983) 1.59
Multiple forms of monoamine oxidase in intact mitochondria as characterized by selective inhibitors and thermal stability: a comparison of eight mammalian species. Adv Biochem Psychopharmacol (1972) 1.43
Urinary and brain beta-carboline-3-carboxylates as potent inhibitors of brain benzodiazepine receptors. Proc Natl Acad Sci U S A (1980) 1.25
Antagonistic effects of apomorphine and haloperidol on rat striatal synaptosomal tyrosine hydroxylase. J Pharm Pharmacol (1974) 1.23
Some properties of brain specific benzodiazepine receptors: new evidence for multiple receptors. Pharmacol Biochem Behav (1979) 1.19
Pharmacological characterization of benzodiazepine receptors in the brain. Eur J Pharmacol (1978) 1.18
Biochemical differentiation of amphetamine vs methylphenidate and nomifensine in rats. J Pharm Pharmacol (1977) 1.04
In vivo measurement of dopamine receptors in human brain by positron emission tomography. Age and sex differences. Ann N Y Acad Sci (1988) 1.02
Additional evidence for the existence of several forms of mitochondrial monoamine oxidase in the mouse. Biochem Pharmacol (1968) 1.02
Methylphenidate-like effects of the new antidepressant drug nomifensine (HOE 984). Eur J Pharmacol (1976) 1.01
Evidence for a late evolutionary appearance of brain-specific benzodiazepine receptors: an investigation of 18 vertebrate and 5 invertebrate species. Brain Res (1978) 1.01
GABA reduces binding of 3H-methyl beta-carboline-3-carboxylate to brain benzodiazepine receptors. Nature (1981) 1.00
[3H]Propyl beta-carboline-3-carboxylate as a selective radioligand for the BZ1 benzodiazepine receptor subclass. J Neurochem (1981) 1.00
Benzodiazepine receptor ligands with positive and negative efficacy. Neuropharmacology (1983) 1.00
Characterization of tiagabine (NO-328), a new potent and selective GABA uptake inhibitor. Eur J Pharmacol (1991) 0.99
Convulsant potencies of tetrazoles are highly correlated with actions on GABA/benzodiazepine/picrotoxin receptor complexes in brain. Life Sci (1984) 0.98
Pharmacological and biochemical studies on 2-amino-4-phenylsulphonylbenzenesulphonamide (NSD 3004): a new sulphonamide with anticonvulsant and carbonic anhydrase inhibitory properties. Acta Pharmacol Toxicol (Copenh) (1971) 0.96
The inhibition of A and B forms of MAO in the production of a characteristic behabioural syndrome in rats after 1-tryptophan loading. Psychopharmacologia (1975) 0.93
Differential pharmacological effects of benzodiazepine receptor inverse agonists. Adv Biochem Psychopharmacol (1983) 0.92
Ethyl beta-carboline-3-carboxylate shows differential benzodiazepine receptor interaction. Nature (1980) 0.91
Uptake inhibition of biogenic amines by newer antidepressant drugs: relevance to the dopamine hypothesis of depression. Psychopharmacology (Berl) (1977) 0.90
Benzodiazepine receptors. Arzneimittelforschung (1980) 0.90
Evaluation of the beta-carboline ZK 93 426 as a benzodiazepine receptor antagonist. Psychopharmacology (Berl) (1984) 0.88
GABAA receptor blockers reverse the inhibitory effect of GABA on brain-specific [35S]TBPS binding. Brain Res (1987) 0.87
The monoamine oxidase B inhibitor deprenyl potentiates phenylethylamine behaviour in rats without inhibition of catecholamine metabolite formation. Eur J Pharmacol (1975) 0.87
Benzodiazepine receptor multiplicity. Neuropharmacology (1983) 0.87
High affinity of the naturally-occurring biflavonoid, amentoflavon, to brain benzodiazepine receptors in vitro. Biochem Pharmacol (1988) 0.87
Ligands for benzodiazepine receptors with positive and negative efficacy. Biochem Pharmacol (1984) 0.86
Evidence that the anticonflict effect of midazolam in amygdala is mediated by the specific benzodiazepine receptors. Neurosci Lett (1985) 0.86
The apparent target size of rat brain benzodiazepine receptor, acetylcholinesterase, and pyruvate kinase is highly influenced by experimental conditions. J Biol Chem (1988) 0.85
Mono N-aryl ethylenediamine and piperazine derivatives are GABAA receptor blockers: implications for psychiatry. Neurochem Res (1993) 0.85
Evidence that 5-methoxy-N, N-dimethyl tryptamine is a specific substrate for MAO-A in the rat: implications for the indoleamine dependent behavioural syndrome. J Neurochem (1975) 0.85
Does the reversal of the anticonflict effect of phenobarbital by beta-CCE and FG 7142 indicate benzodiazepine receptor-mediated anxiogenic properties? Eur J Pharmacol (1982) 0.84
Noradrenergic influence on the stereotyped behaviour induced by amphetamine, phenethylamine and apomorphine. J Pharm Pharmacol (1976) 0.84
NNC-112, NNC-687 and NNC-756, new selective and highly potent dopamine D1 receptor antagonists. Eur J Pharmacol (1992) 0.83
Gas chromatographic evidence for the presence of 3-methoxy-4-hydroxyphenylethanol in rat brain. Biochem Pharmacol (1972) 0.83
Evidence for different states of the dopamine D1 receptor: clozapine and fluperlapine may preferentially label an adenylate cyclase-coupled state of the D1 receptor. J Neurochem (1986) 0.82
Enhancement of 3H-diazepam binding by SQ 65,396: a novel anti-anxiety agent. Pharmacol Biochem Behav (1978) 0.82
Anticonvulsant action in the photosensitive baboon, Papio papio, of a novel beta-carboline derivative, ZK 91296. Eur J Pharmacol (1983) 0.82
Some pharmacological and biochemical properties of gamma-morpholino-butyrophenone (NSD 2023), a new monoamine oxidase inhibitor. Biochem Pharmacol (1968) 0.82
Partial agonists for brain GABA/benzodiazepine receptor complex. Nature (1979) 0.82
ZK 91296, a partial agonist at benzodiazepine receptors. Psychopharmacology (Berl) (1984) 0.82
Some properties of 3H-diazepam displacing activity from human urine. Life Sci (1979) 0.81
Accumulation and disappearance of noradrenaline and its major metabolites synthesized from intraventricularly injected (3H)dopamine in the rat brain. J Neurochem (1974) 0.81
Anxiety. Lancet (1982) 0.81
Effects of the beta-carboline, FG 7142, in the social interaction test of anxiety and the holeboard: correlations between behaviour and plasma concentrations. Pharmacol Biochem Behav (1985) 0.80
Identification of free and conjugated 3-methoxy-4-hydroxyphenylglycol (MOPEG) in rat brain by gas chromatography and mass fragmentography. Anal Biochem (1973) 0.80
Development of 123I-labelled NNC 13-8241 as a radioligand for SPECT visualization of benzodiazepine receptor binding. Nucl Med Biol (1996) 0.80
Neurochemical and pharmacological studies on a new 5HT-uptake inhibitor, FG4963, with potential antidepressant properties. Psychopharmacologia (1975) 0.80
Regional distribution of the synaptic membrane proteins: synaptin, D1, D2 and D3. J Neurochem (1978) 0.80
Benzodiazepine receptors in the brain as affected by different experimental stresses: the changes are small and not undirectional. Psychopharmacology (Berl) (1979) 0.79
3-Methoxy-4-hydroxyphenylethanol in the rat brain. J Neurochem (1973) 0.79
Binding of [3H]DMCM, a convulsive benzodiazepine ligand, to rat brain membranes: preliminary studies. J Neurochem (1983) 0.79
The effects of FG 7142 and RO 15-1788 on the release of punished responding produced by chlordiazepoxide and ethanol in the rat. Psychopharmacology (Berl) (1986) 0.79
Glycine antagonists structurally related to 4,5,6,7-tetrahydroisoxazolo [5,4-c]pyridin-3-ol inhibit binding of [3H]strychnine to rat brain membranes. J Neurochem (1986) 0.79
Interaction of pitrazepin with the GABA/benzodiazepine receptor complex and with glycine receptors. Eur J Pharmacol (1985) 0.79
Binding of 3H-DMCM to benzodiazepine receptors; chloride dependent allosteric regulation mechanisms. J Neural Transm (1983) 0.78
Changes in drug-induced stereotyped behavior after 6-OHDA lesions in noradrenaline neurons. Psychopharmacology (Berl) (1977) 0.78
Antagonistic effects of neuroleptics and apomorphine on synaptosomal tyrosine hydroxylase in vitro. J Pharm Pharmacol (1974) 0.78
Audiogenic seizures in DBA/2 mice discriminate sensitively between low efficacy benzodiazepine receptor agonists and inverse agonists. Life Sci (1983) 0.78
Radiation inactivation of brain [35S]t-butylbicyclophosphorothionate binding sites reveals complicated molecular arrangements of the GABA/benzodiazepine receptor chloride channel complex. Biochem Pharmacol (1985) 0.78
A method for the assay of conjugated 3,4-dihydroxyphenylglycol, a major noradrenaline metabolite in the rat brain. J Neurochem (1976) 0.78
GABA-dopamine interaction in substantia nigra and nucleus accumbens--relevance to behavioral stimulation and stereotyped behavior. Adv Biochem Psychopharmacol (1978) 0.78
Characteristics and regional distributions of two distinct [3H]naloxone binding sites in the rat brain. J Neurochem (1978) 0.78
Enhanced binding of the convulsive ligand DMCM to high-energy irradiated benzodiazepine receptors; evidence of complex receptor structure. Biochem Pharmacol (1983) 0.77
Effects of the antidepressant pirlindole and its dehydro-derivative on the activity of monoamine oxidase-A and on GABAA receptors. Neurochem Res (1996) 0.77
No changes in rat benzodiazepine receptors after withdrawal from continuous treatment with lorazepam and diazepam. Life Sci (1979) 0.77
Behavioural effects of d-amphetamine in young chicks treated with p-Cl-phenylalanine. Psychopharmacologia (1971) 0.77
Modulation of GABA binding to rat brain membranes by alkyl beta-carboline-3-carboxylate esters. Eur J Pharmacol (1982) 0.77
Two or more conformations of benzodiazepine receptors depending on GABA receptors and other variables. Adv Biochem Psychopharmacol (1980) 0.77
Specific 3H-DMCM binding to a non-benzodiazepine binding site after silver ion treatment of rat brain membranes. Life Sci (1984) 0.77
gamma-aminobutyric acid receptors modulate cation binding sites coupled to independent benzodiazepine, picrotoxin, and anion binding sites. Mol Pharmacol (1982) 0.77
Excitatory amino acids: role in morphine excitation in rat periaqueductal gray. Behav Brain Res (1988) 0.76
Apomorphine-induced stereotyped biting in the tortoise in relation to dopaminergic mechanisms. Brain Behav Evol (1975) 0.76
Some atypical neuroleptics inhibit [3H]SCH 23390 binding in vivo. Eur J Pharmacol (1986) 0.76
Saturable binding of 35S-t-butylbicyclophosphorothionate to the sites linked to the GABA receptor and the interaction with GABAergic agents. Life Sci (1984) 0.76
The influence of the antidepressant pirlindole and its dehydro-derivative on the activity of monoamine oxidase A and GABAA receptor binding. J Neural Transm Suppl (1998) 0.76
GABA receptors regulate the affinities of anions required for brain specific benzodiazepine binding. Adv Biochem Psychopharmacol (1981) 0.76
[3H]propyl beta-carboline-3-carboxylate binds specifically to brain benzodiazepine receptors. J Neurochem (1981) 0.76
Desipramine and some other antidepressant drugs decrease the major norepinephrine metabolite 3,4-dihydroxyphenylglycol-sulphate in the rat brain. Naunyn Schmiedebergs Arch Pharmacol (1977) 0.75
Effects of phenoxybenzamine, aceperone and clonidine on the level of 3-methoxy-4-hydroxyphenylglycol (MOPEG) in rat brain. J Pharm Pharmacol (1974) 0.75
Benzodiazepine receptor ligands with negative efficacy: chloride channel coupling. Adv Biochem Psychopharmacol (1983) 0.75
The distribution of 2-amino-4-phenylsulphonylbenzenesulphonamide (NSD 3004) in blood and its binding to blood components. Acta Pharmacol Toxicol (Copenh) (1971) 0.75
[Research on receptors and their psychiatric perspectives]. Nord Med (1983) 0.75
Benzodiazepine receptor ligands with positive and negative efficacy. Adv Biochem Psychopharmacol (1983) 0.75
Reduction of 3H-spiroperidol binding in rat striatum and frontal cortex by chronic amphetamine: dose response, time course and role of sustained dopamine release. Psychopharmacology (Berl) (1983) 0.75
Are polioviruses a cause of schizophrenia? Br J Psychiatry (1992) 0.75